Priority review voucher updates: Who's won PRVs, who's bought them, and how much they're selling for
Tracker updated on 4/29/25 to note that Novartis said it used a PRV to speed up the FDA’s review of remibrutinib, an oral treatment for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
